Self-assembled vehicle construction via boronic acid coupling and host-guest interaction for serum-tolerant DNA transport and pH-responsive drug delivery

Advanced Healthcare Materials

Volumn 3, Issue 4, 2014, Pages 596-608

  Yang, Bin ^a   Jia, Huizhen ^a   Wang, Xuli ^b   Chen, Si ^a   Zhang, Xianzheng ^a   Zhuo, Renxi ^a   Feng, Jun ^a  

^a WUHAN UNIVERSITY   (China)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Drug inclusion; Gene delivery; PH responsive drug release; Serum tolerability

Indexed keywords

ACIDITY; BIOCOMPATIBILITY; CELL MEMBRANES; CONTROLLED DRUG DELIVERY; DISEASES; EFFICIENCY; GENE TRANSFER; GENES; MOLECULAR BIOLOGY; ORGANIC ACIDS; PH; TARGETED DRUG DELIVERY;

CELL BIOCOMPATIBILITIES; DRUG RELEASE; GENE DELIVERY; HOST GUEST INTERACTIONS; LUCIFERASE EXPRESSION; SERUM-TOLERABILITY; TRANSFECTION ACTIVITY; TRANSFECTION EFFICIENCY;

DRUG INTERACTIONS;

CURCUMIN; DOXORUBICIN; LUCIFERASE; NANOCARRIER; PEI25K GENE CARRIER; PHENYLBORONIC ACID MODIFIED OLIGOETHYLENIMINE; PHENYLBORONIC ACID MODIFIED OLIGOETHYLENIMINE GAMMA CYCLODEXTRIN NANOCARRIER; PLASMID DNA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BENZENEBORONIC ACID; BIOMATERIAL; BORONIC ACID DERIVATIVE; DRUG CARRIER; GAMMA CYCLODEXTRIN DERIVATIVE;

ADSORPTION KINETICS; ARTICLE; BINDING AFFINITY; BIOCHEMISTRY; BIOCOMPATIBILITY; BORONIC ACID COUPLING; CANCER CHEMOTHERAPY; CELL STRAIN HEK293; CELL VIABILITY; CHEMICAL REACTION; COMPARATIVE STUDY; CONTROLLED STUDY; COVALENT BOND; DNA NANOFORMULATION; DNA TRANSFER; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMBRYO; FEMALE; GENETIC TRANSFECTION; HELA CELL; HOST-GUEST CHEMISTRY; HUMAN; HUMAN CELL; IN VITRO STUDY; NANOBIOTECHNOLOGY; PH; PH RESPONSIVE GENE DRUG CO-DELIVERY NANOSYSTEM; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SERUM FREE TRANSFECTION; SERUM PRESENT TRANSFECTION; STRUCTURE ACTIVITY RELATION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE TRANSFER; HEK293 CELL LINE;

ANTINEOPLASTIC AGENTS; BIOCOMPATIBLE MATERIALS; BORONIC ACIDS; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; GAMMA-CYCLODEXTRINS; GENE TRANSFER TECHNIQUES; HEK293 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION;

EID: 84898627420     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201300162     Document Type: Article

References (59)

1. a) Y. Wang, S. J. Gao, W. H. Ye, H. S. Yoon, Y. Y. Yang, Nat. Mater. 2006, 5, 791
2. b) M. Creixell, N. A. Peppas, Nano Today 2012, 7, 367.
3. a) A. L. Z. Lee, Y. Wang, H. Y. Cheng, S. Pervaiz, Y. Y. Yang, Biomaterials 2009, 30, 919
4. b) H. A. Meng, M. Liong, T. A. Xia, Z. X. Li, Z. X. Ji, J. I. Zink, A. E. Nel, ACS Nano 2010, 4, 4539
5. c) X. B. Xiong, A. Lavasanifar, ACS Nano 2011, 5, 5202
6. d) H. Fan, Q. D. Hu, F. J. Xu, W. Q. Liang, G. P. Tang, W. T. Yang, Biomaterials 2012, 33, 1428
7. e) M. Saad, O. B. Garbuzenko, T. Minko, Nanomedicine 2008, 3, 761.
8. Y. Wang, J. D. Byrne, M. E. Napier, J. M. DeSimone, Adv. Drug Delivery Rev. 2012, 64, 1021.
9. M. A. Mintzer, E. E. Simanek, Chem. Rev. 2009, 109, 259.
10. a) Y. P. Li, W. W. Xiao, K. Xiao, L. Berti, J. T. Luo, H. P. Tseng, G. Fung, K. S. Lam, Angew. Chem. Int. Ed. 2012, 51, 2864
11. b) J. Su, F. Chen, V. L. Cryns, P. B. Messersmith, J. Am. Chem. Soc. 2011, 133, 11850
12. c) W. Q. Yang, X. M. Gao, B. H. Wang, Med. Res. Rev. 2003, 23, 346.
13. B. K. Gorityala, Z. Q. Lu, M. L. Leow, J. M. Ma, X. W. Liu, J. Am. Chem. Soc. 2012, 134, 15229.
14. T. G. Park, J. H. Jeong, S. W. Kim, Adv. Drug. Delivery Rev. 2006, 58, 467.
15. R. Srinivas, S. Samanta, A. Chaudhuri, Chem. Soc. Rev. 2009, 38, 3326.
16. C. Pichon, L. Billiet, P. Midoux, Curr. Opin. Biotechnol. 2010, 21, 640.
17. H. Y. Wang, J. X. Chen, Y. X. Sun, J. Z. Deng, C. Li, X. Z. Zhang, R. X. Zhuo, J. Controlled Release 2011, 155, 26.
18. J. N. Cambre, B. S. Sumerlin, Polymer 2011, 52, 4631.
19. E. Redenti, C. Pietra, A. Gerloczy, L. Szente, Adv. Drug. Delivery Rev. 2001, 53, 235.
20. C. O. Mellet, J. M. G. Fernandez, J. M. Benito, Chem. Soc. Rev. 2011, 40, 1586.
21. a) G. Chen, M. Jiang, Chem. Soc. Rev. 2011, 40, 2254
22. b) J. X. Zhang, P. X. Ma, Nano Today 2010, 5, 337.
23. Q. Peng, F. J. Chen, Z. L. Zhong, R. X. Zhuo, Chem. Commun. 2010, 46, 5888.
24. Q. C. Wang, Q. Ma, D. H. Qu, H. Tian, Chem. Eur. J. 2006, 12, 1088.
25. a) T. D. James, K. Sandanayake, S. Shinkai, Angew. Chem. Int. Ed. 1994, 33, 2207
26. b) T. D. James, K. Sandanayake, R. Iguchi, S. Shinkai, J. Am. Chem. Soc. 1995, 117, 8982.
27. a) D. Fischer, T. Bieber, Y. X. Li, H. P. Elsasser, T. Kissel, Pharm. Res. 1999, 16, 1273
28. b) O. Boussif, F. Lezoualc'h, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, J. P. Behr, Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 7297.
29. M. Naito, T. Ishii, A. Matsumoto, K. Miyata, Y. Miyahara, K. Kataoka, Angew. Chem. Int. Ed. 2012, 51, 10751.
30. A. Matsumoto, N. Sato, K. Kataoka, Y. Miyahara, J. Am. Chem. Soc. 2009, 131, 12022.
31. M. Piest, J. F. J. Engbersen, J. Controlled Release 2011, 155, 331.
32. G. A. Ellis, M. J. Palte, R. T. Raines, J. Am. Chem. Soc. 2012, 134, 3631.
33. S. H. Pun, N. C. Bellocq, A. J. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. F. Wen, H. Engler, J. Heidel, M. E. Davis, Bioconjugate Chem. 2004, 15, 831.
34. X. H. Luo, F. W. Huang, S. Y. Qin, H. F. Wang, J. Feng, X. Z. Zhang, R. X. Zhuo, Biomaterials 2011, 32, 9925.
35. a) A. K. Pannier, J. A. Wieland, L. D. Shea, Acta Biomater. 2008, 4, 26
36. b) B. Yang, Y. X. Sun, W. J. Yi, J. Yang, C. W. Liu, H. Cheng, J. Feng, X. Z. Zhang, R. X. Zhuo, Acta Biomater. 2012, 8, 2121.
37. a) A. T. Wright, Z. L. Zhong, E. V. Anslyn, Angew. Chem. Int. Ed. 2005, 44, 5679
38. b) M. Y. Li, N. Lin, Z. Huang, L. P. Du, C. Altier, H. Fang, B. H. Wang, J. Am. Chem. Soc. 2008, 130, 12636.
39. a) A. Jain, R. J. Liu, Y. K. Xiang, T. Ha, Nat. Protoc. 2012, 7, 445
40. b) Z. Amoozgar, Y. Yeo, Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2012, 4, 219
41. c) L.M. Lopez-Marin, E. Tamariz, L.S. Acosta-Torres, V. M. Castano, Curr. Drug Metab. 2012, E-published ahead of print.
42. a) L. X. Song, L. Bai, X. M. Xu, J. He, S. Z. Pan, Coordin. Chem. Rev. 2009, 253, 1276
43. b) F. van de Manakker, T. Vermonden, C.F. van Nostrum, W. E. Hennink, Biomacromolecules 2009, 10, 3157
44. c) J. Li, X. J. Loh, Adv. Drug Delivery Rev. 2008, 60, 1000.
45. a) N. Husain, T. T. Ndou, A.M. De La Pena, I. M. Warner, Appl. Spectrosc. 1992, 46, 652
46. b) J. M. Li, Y. Y. Wang, M. X. Zhao, C. P. Tan, Y. Q. Li, X. Y. Le, L. N. Ji, Z. W. Mao, Biomaterials 2012, 33, 2780.
47. a) A. D. Stuart, T. D. K. Brown, J. Gen. Virol. 2007, 88, 177
48. b) Q. S. Wen, C. L. Zhu, L. B. Liu, Q. Yang, S. Wang, D. B. Zhu, Macromol. Chem. Phys. 2012, 213, 2486.
49. a) G. Springsteen, B. H. Wang, Tetrahedron 2002, 58, 5291
50. b) J. Yan, G. Springsteen, S. Deeter, B. H. Wang, Tetrahedron 2004, 60, 11205.
51. a) Y. L. Zhao, Z. X. Li, S. Kabehie, Y. Y. Botros, J. F. Stoddart, J. I. Zink, J. Am. Chem. Soc. 2010, 132, 13016
52. b) S. M. Lee, H. Chen, C. M. Dettmer, T. V. O'Halloran, S. T. Nguyen, J. Am. Chem. Soc. 2007, 129, 15096
53. c) A. P. Griset, J. Walpole, R. Liu, A. Gaffey, Y. L. Colson, M. W. Grinstaff, J. Am. Chem. Soc. 2009, 131, 2469.
54. a) J. Z. Du, X. J. Du, C. Q. Mao, J. Wang, J. Am. Chem. Soc. 2011, 133, 17560;
55. b) M. Murakami, H. Cabral, Y. Matsumoto, S. R. Wu, M. R. Kano, T. Yamori, N. Nishiyama, K. Kataoka, Sci. Transl. Med. 2011, 3, 64ra2
56. c) R. Mo, Q. Sun, J. W. Xue, N. Li, W. Y. Li, C. Zhang, Q. N. Ping, Adv. Mater. 2012, 24, 3659.
57. a) S. S. Dhule, P. Penfornis, T. Frazier, R. Walker, J. Feldman, G. Tan, J. B. He, A. Alb, V. John, R. Pochampally, Nanomed.-Nanotechnol. Biol. Med. 2012, 8, 440
58. b) V. R. Yadav, S. Prasad, R. Kannappan, J. Ravindran, M. M. Chaturvedi, L. Vaahtera, J. Parkkinen, B. B. Aggarwal, Biochem. Pharmacol. 2010, 80, 1021
59. c) M. M. Yallapu, S. F. Othman, E. T. Curtis, B. K. Gupta, M. Jaggi, S. C. Chauhan, Biomaterials 2011, 32, 1890.